Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
ProQR Therapeutics N.V.(NASDAQ: PRQR)*

Organization & Developments: ProQR Therapeutics

Parents

2019: Biotech Analysis Central Preview Series: ProQR Therapeutics_seekingalpha.com
2019: ProQR Therapeutics: An In-Depth Assessment_seekingalpha.com
2020: ProQR Therapeutics Is A Worthy Play
2021: Pounding The Table For ProQR Therapeutics
Its approach is to leverage RNA therapies, which allows it to address inherited diseases caused by a genetic defect.
The drugs are comprised of short pieces of synthetic RNA that enable corrections to genes, which ultimately restore protein expression that is critical for one’s body to function properly.